Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 19, Issue 4
Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Therapeutics
Systematic review and meta-analysis
Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma
Online download statistics by month:
Online download statistics by month: March 2014 to September 2024
Abstract
Full
Pdf
Mar 2014
201
13
25
Apr 2014
119
4
18
May 2014
38
1
4
Jun 2014
43
1
11
Jul 2014
188
19
20
Aug 2014
105
13
22
Sep 2014
113
17
21
Oct 2014
21
12
8
Nov 2014
29
10
5
Dec 2014
25
3
5
Jan 2015
25
8
4
Feb 2015
25
5
4
Mar 2015
38
3
5
Apr 2015
28
4
3
May 2015
19
10
9
Jun 2015
9
2
2
Jul 2015
34
5
6
Aug 2015
15
1
1
Sep 2015
32
4
4
Oct 2015
5
1
0
Nov 2015
17
2
3
Dec 2015
45
1
4
Jan 2016
40
4
9
Feb 2016
23
4
6
Mar 2016
3
3
3
Apr 2016
19
1
3
May 2016
35
3
3
Jun 2016
14
3
5
Jul 2016
10
1
0
Aug 2016
22
0
1
Sep 2016
20
3
3
Oct 2016
38
1
3
Nov 2016
52
1
5
Dec 2016
14
0
0
Jan 2017
16
0
1
Feb 2017
24
2
3
Mar 2017
10
3
1
Apr 2017
25
2
1
May 2017
27
4
1
Jun 2017
10
0
0
Jul 2017
26
4
0
Aug 2017
24
2
0
Sep 2017
47
1
1
Oct 2017
31
2
1
Nov 2017
30
2
2
Dec 2017
26
4
2
Jan 2018
37
2
1
Feb 2018
29
0
1
Mar 2018
38
2
1
Apr 2018
33
3
2
May 2018
37
1
1
Jun 2018
46
1
1
Jul 2018
33
1
0
Aug 2018
36
2
2
Sep 2018
23
1
0
Oct 2018
45
0
0
Nov 2018
55
1
0
Dec 2018
68
2
1
Jan 2019
50
2
1
Feb 2019
56
2
0
Mar 2019
25
0
0
Apr 2019
17
1
0
May 2019
15
1
0
Jun 2019
8
1
0
Jul 2019
25
2
0
Aug 2019
20
0
0
Sep 2019
14
0
2
Oct 2019
25
0
0
Nov 2019
20
0
0
Dec 2019
23
1
0
Jan 2020
28
3
3
Feb 2020
47
0
1
Mar 2020
9
1
0
Apr 2020
22
3
2
May 2020
30
0
2
Jun 2020
24
0
0
Jul 2020
25
1
1
Aug 2020
14
0
1
Sep 2020
33
0
0
Oct 2020
29
4
0
Nov 2020
38
0
1
Dec 2020
17
1
1
Jan 2021
28
2
0
Feb 2021
8
0
0
Mar 2021
30
0
0
Apr 2021
17
0
0
May 2021
2
0
0
Jul 2021
6
2
1
Aug 2021
3
0
1
Sep 2021
5
0
0
Oct 2021
11
1
0
Nov 2021
20
0
0
Dec 2021
23
0
0
Jan 2022
25
1
3
Feb 2022
34
0
0
Mar 2022
25
0
0
Apr 2022
31
0
0
May 2022
60
0
2
Jun 2022
42
0
0
Jul 2022
31
1
0
Aug 2022
48
1
0
Sep 2022
26
0
0
Oct 2022
52
1
0
Nov 2022
50
4
1
Dec 2022
19
0
0
Jan 2023
21
2
1
Feb 2023
55
2
0
Mar 2023
20
1
0
Apr 2023
5
1
0
May 2023
31
0
0
Jun 2023
8
0
2
Jul 2023
38
0
0
Aug 2023
45
2
0
Sep 2023
10
0
0
Oct 2023
24
0
0
Nov 2023
56
1
0
Dec 2023
38
2
0
Jan 2024
8
0
1
Feb 2024
40
1
0
Mar 2024
43
2
2
Apr 2024
47
0
0
May 2024
21
1
0
Jun 2024
115
0
0
Jul 2024
34
3
0
Aug 2024
20
0
0
Sep 2024
45
1
1
Total
4174
260
278
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF